134 related articles for article (PubMed ID: 2481871)
1. [An immunohistochemical study on primary carcinoma of the liver].
Seo JK
J UOEH; 1989 Dec; 11(4):429-39. PubMed ID: 2481871
[TBL] [Abstract][Full Text] [Related]
2. Tissue polypeptide antigen--a marker antigen differentiating cholangiolar tumors from other hepatic tumors.
Pastolero GC; Wakabayashi T; Oka T; Mori S
Am J Clin Pathol; 1987 Feb; 87(2):168-73. PubMed ID: 3028121
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.
Haratake J; Hashimoto H
Liver; 1995 Feb; 15(1):9-15. PubMed ID: 7539881
[TBL] [Abstract][Full Text] [Related]
4. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Ma CK; Zarbo RJ; Frierson HF; Lee MW
Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
7. Letter: Alpha fetoprotein and cholangiocellular carcinoma.
Villeneuve JP; Richer G; Côté J; Joly JG; Marleau D; Viallet A
N Engl J Med; 1974 May; 290(22):1260. PubMed ID: 4133098
[No Abstract] [Full Text] [Related]
8. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
[TBL] [Abstract][Full Text] [Related]
9. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG
Oncology; 1989; 46(6):381-5. PubMed ID: 2479897
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma.
Johnson DE; Herndier BG; Medeiros LJ; Warnke RA; Rouse RV
Am J Surg Pathol; 1988 Mar; 12(3):187-97. PubMed ID: 2449824
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
12. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
[TBL] [Abstract][Full Text] [Related]
13. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
[TBL] [Abstract][Full Text] [Related]
14. [Tissue polypeptide antigen (TPA) in liver tissue from patients with hepatocellular carcinoma].
Onji M; Danjo K; Miyaoka H; Taniguchi Y; Ohta Y
Nihon Shokakibyo Gakkai Zasshi; 1987 Nov; 84(11):2537-41. PubMed ID: 2831415
[No Abstract] [Full Text] [Related]
15. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
Herrmann G
Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
[TBL] [Abstract][Full Text] [Related]
17. Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.
Heyderman E; Larkin SE; O'Donnell PJ; Haines AM; Warren PJ; Northeast A; Grant AG
J Clin Pathol; 1990 Jun; 43(6):448-52. PubMed ID: 1696288
[TBL] [Abstract][Full Text] [Related]
18. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), and keratin on mammary and extramammary Paget's disease.
Mori O; Hachisuka H; Sasai Y
Acta Histochem; 1989; 85(1):93-100. PubMed ID: 2469278
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
Ferrandez-Izquierdo A; Llombart-Bosch A
Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
